A Pilot Study of Early PET and Biomarker Dynamics in Patients with Stage 2 and 3 Triple Negative Breast Cancer Treated with Neoadjuvant Response-Adapted Chemotherapy with Pembrolizumab (Neoadapt).
Journal of Clinical Oncology（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要